The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation

被引:38
作者
Balabanova, Y
Drobniewski, F
Fedorin, I
Zakharova, S
Nikolayevskyy, V
Atun, R
Coker, R
机构
[1] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England
[2] St Bartholomew & Queen Mary Sch Med, Clin TB & HIV Grp, HPA Mycobacterium Reference Unit, London E1 2AT, England
[3] Samara Oblast TB Dispensary, Samara 443068, Russia
[4] Samara City TB Dispensary N1, Samara 443001, Russia
[5] Univ London Imperial Coll Sci Technol & Med, Tanaka Business Sch, Ctr Hlth Management, London SW7 2AZ, England
来源
RESPIRATORY RESEARCH | 2006年 / 7卷 / 1期
关键词
D O I
10.1186/1465-9921-7-44
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: The World Health Organisation ( WHO) defines Russia as one of the 22 highest-burden countries for tuberculosis ( TB). The WHO Directly Observed Treatment Short Course ( DOTS) strategy employing a standardised treatment for 6 months produces the highest cure rates for drug sensitive TB. The Russian TB service traditionally employed individualised treatment. The purpose of this study was to implement a DOTS programme in the civilian and prison sectors of Samara Region of Russia, describe the clinical features and outcomes of recruited patients, determine the proportion of individuals in the cohorts who were infected with drug resistant TB, the degree to which resistance was attributed to the Beijing TB strain family and establish risk factors for drug resistance. Methods: prospective study Results: 2,099 patients were recruited overall. Treatment outcomes were analysed for patients recruited up to the third quarter of 2003 ( n = 920). 75.3% of patients were successfully treated. Unsuccessful outcomes occurred in 7.3% of cases; 3.6% of patients died during treatment, with a significantly higher proportion of smear-positive cases dying compared to smear-negative cases. 14.0% were lost and transferred out. A high proportion of new cases ( 948 sequential culture-proven TB cases) had tuberculosis that was resistant to first-line drugs; (24.9% isoniazid resistant; 20.3% rifampicin resistant; 17.3% multidrug resistant tuberculosis). Molecular epidemiological analysis demonstrated that half of all isolated strains (50.7%; 375/740) belonged to the Beijing family. Drug resistance including MDR TB was strongly associated with infection with the Beijing strain ( for MDR TB, 35.2% in Beijing strains versus 9.5% in non-Beijing strains, OR-5.2. Risk factors for multidrug resistant tuberculosis were: being a prisoner ( OR 4.4), having a relapse of tuberculosis ( OR 3.5), being infected with a Beijing family TB strain ( OR 6.5) and having an unsuccessful outcome from treatment ( OR 5.0). Conclusion: The implementation of DOTS in Samara, Russia, was feasible and successful. Drug resistant tuberculosis rates in new cases were high and challenge successful outcomes from a conventional DOTS programme alone.
引用
收藏
页数:10
相关论文
共 31 条
[1]  
[Anonymous], 1997, TREATM TUB GUID NAT
[2]  
Atun RA, 2005, INT J TUBERC LUNG D, V9, P1140
[3]  
Atun RA, 2005, B WORLD HEALTH ORGAN, V83, P730
[4]   Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions [J].
Atun, RA ;
Samyshkin, YA ;
Drobniewski, F ;
Kuznetsov, SI ;
Fedorin, IM ;
Coker, RJ .
EUROPEAN JOURNAL OF PUBLIC HEALTH, 2005, 15 (04) :350-354
[5]  
Atun RA, 2005, B WORLD HEALTH ORGAN, V83, P217
[6]   Variability in interpretation of chest radiographs among Russian clinicians and implications for screening programmes: observational study [J].
Balabanova, Y ;
Coker, R ;
Fedorin, I ;
Zakharova, S ;
Plavinskij, S ;
Krukov, N ;
Atun, R ;
Drobniewski, F .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7513) :379-+
[7]   Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy [J].
Balabanova, Y ;
Ruddy, M ;
Hubb, J ;
Yates, M ;
Malomanova, N ;
Fedorin, I ;
Drobniewski, F .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (02) :136-139
[8]   Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance? [J].
Balabanova, Y ;
Fedorin, I ;
Kuznetsov, S ;
Graham, C ;
Ruddy, M ;
Atun, R ;
Coker, R ;
Drobniewski, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (03) :673-679
[9]  
*CHIN TUB CONTR CO, 2004, LANCET, P417
[10]   Health system frailties in tuberculosis service provision in Russia: an analysis through the lens of formal nutritional support [J].
Coker, RJ ;
Dimitrova, B ;
Drobniewski, F ;
Samyshkin, Y ;
Pomerleau, J ;
Hohlova, GY ;
Skuratova, N ;
Kuznetsov, S ;
Fedorin, I ;
Atun, R .
PUBLIC HEALTH, 2005, 119 (09) :837-843